Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation - Badrising, S K; van der Noort, V; van den Eertwegh, A J (Prostate, 2016)
et al.